|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 10)*
|
AIM IMMUNOTECH INC. (Name of Issuer) |
Common Stock, par value $0.001 per share (Title of Class of Securities) |
00901B105 (CUSIP Number) |
Todd Deutsch c/o Baker & Hostetler LLP, 127 Public Sq, Suite 2000 Attn: John J. Harrington Cleveland, OH, 44114 (216) 621-0200 Ted D. Kellner c/o Baker & Hostetler LLP, 127 Public Sq, Suite 2000 Attn: John J. Harrington Cleveland, OH, 44114 (216) 621-0200 Paul W. Sweeney c/o Baker & Hostetler LLP, 127 Public Sq, Suite 2000 Attn: John J. Harrington Cleveland, OH, 44114 (216) 621-0200 Wayne Springate c/o Baker & Hostetler LLP, 127 Public Sq, Suite 2000 Attn: John J. Harrington Cleveland, OH, 44114 (216) 621-0200 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
12/19/2024 (Date of Event Which Requires Filing of This Statement) |
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
SCHEDULE 13D
|
| CUSIP No. | 00901B105 |
| 1 |
Name of reporting person
Todd Deutsch | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
 (b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
1,716,100.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
2.7 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
Comment for Type of Reporting Person:
Percentage ownership based on 63,779,325 shares outstanding as reported in a Prospectus filed by the Company pursuant to Rule 424(b)(5) on December 4, 2024 with the Securities and Exchange Commission (File No. 333-283269).
SCHEDULE 13D
|
| CUSIP No. | 00901B105 |
| 1 |
Name of reporting person
Ted D. Kellner | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
1,493,000.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
2.3 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
Comment for Type of Reporting Person:
Percentage ownership based on 63,779,325 shares outstanding as reported in a Prospectus filed by the Company pursuant to Rule 424(b)(5) on December 4, 2024 with the Securities and Exchange Commission (File No. 333-283269).
SCHEDULE 13D
|
| CUSIP No. | 00901B105 |
| 1 |
Name of reporting person
Paul W. Sweeney | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
2,000.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
Comment for Type of Reporting Person:
Percentage ownership based on 63,779,325 shares outstanding as reported in a Prospectus filed by the Company pursuant to Rule 424(b)(5) on December 4, 2024 with the Securities and Exchange Commission (File No. 333-283269).
SCHEDULE 13D
|
| CUSIP No. | 00901B105 |
| 1 |
Name of reporting person
Wayne Springate | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
| ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
4,660.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.01 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
Comment for Type of Reporting Person:
Percentage ownership based on 63,779,325 shares outstanding as reported in a Prospectus filed by the Company pursuant to Rule 424(b)(5) on December 4, 2024 with the Securities and Exchange Commission (File No. 333-283269).
SCHEDULE 13D
|
| Item 1. | Security and Issuer | |
| (a) | Title of Class of Securities:
Common Stock, par value $0.001 per share | |
| (b) | Name of Issuer:
AIM IMMUNOTECH INC. | |
| (c) | Address of Issuer's Principal Executive Offices:
2117 SW HIGHWAY 484, OCALA,
FLORIDA
, 32801. | |
Item 1 Comment:
This Amendment No. 10 ("Amendment No. 10") is being filed jointly by Todd Deutsch, Ted. D. Kellner, Paul W. Sweeney and Wayne Springate and amends and supplements the Schedule 13D filed with the Securities and Exchange Commission on July 27, 2023 (the "Initial Schedule 13D" and together with Amendment No. 1 thereto filed on August 7, 2023, Amendment No. 2 thereto filed on August 28, 2023, Amendment No. 3 thereto filed on January 3, 2024, Amendment No. 4 thereto filed on July 15, 2024, Amendment No. 5 thereto filed on July 30, 2024, Amendment No. 6 thereto filed on August 14, 2024, Amendment No. 7 thereto filed on September 3, 2024, Amendment No. 8 thereto filed on September 11, 2024 and Amendment No. 9 thereto filed on December 17, 2024, the "Schedule 13D") by Todd Deutsch, Ted D. Kellner and, in the cases of Amendment No. 8 and 9 thereto, Paul W. Sweeney, and Amendment No. 9 thereto, Wayne Springate, with respect to the Common Stock, par value $0.001 per share, of AIM ImmunoTech Inc. (the "Company").
In this Amendment No. 10, Mr. Deutsch, Mr. Kellner, Mr. Sweeney and Mr. Springate are each a "Reporting Person" and, collectively, the "Reporting Persons." In the Initial Schedule 13D and all prior amendments, "Reporting Persons" refers to Mr. Deutsch and Mr. Kellner, except for Amendment No. 8, in which "Reporting Persons" refer to Mr. Deutsch, Mr. Kellner and Mr. Sweeney, and Amendment No. 9, in which "Reporting Persons" refer to Mr. Deutsch, Mr. Kellner, Mr. Sweeney and Mr. Springate. Capitalized terms used herein and not otherwise defined in this Amendment No. 10 shall have the meanings set forth in the Schedule 13D. This Amendment No. 10 amends Item 5 to the extent set forth below. | ||
| Item 5. | Interest in Securities of the Issuer | |
| (e) | As a result of the termination of the agreement among the Reporting Persons, dated September 3, 2024 and amended September 11, 2024 and December 14, 2024, by its terms following the completion of the Company's annual meeting of stockholders held on December 17, 2024, following the final certification of voting results of the annual meeting on December 19, 2024, each of the Reporting Persons has ceased to be a part of any "group" within the meaning of the Securities Exchange Act of 1934, as amended, among or between the Reporting Persons that is the beneficial owner of more than 5% of the Company's outstanding Common Stock and, accordingly, each of the Reporting Persons has ceased to be the beneficial owner of more than 5% of the Company's outstanding Common Stock. The filing of this Amendment No. 10 represents the final amendment to the Schedule 13D and constitutes an exit filing for each of the Reporting Persons and the Reporting Persons as a group. | |
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|
|
|